Aigen Investment Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,465
Closed -$643K 789
2025
Q3
$643K Sell
4,465
-11,496
-72% -$1.41M 0.1% 321
2025
Q2
$1.61M Buy
+15,961
New +$1.22M 0.22% 140
2025
Q1
Sell
-11,936
Closed -$824K 879
2024
Q4
$824K Buy
11,936
+7,867
+193% +$567K 0.15% 208
2024
Q3
$297K Buy
+4,069
New +$300K 0.06% 475
2023
Q1
Sell
-18,127
Closed -$362K 710
2022
Q4
$362K Buy
+18,127
New +$350K 0.05% 329
2022
Q2
Sell
-18,218
Closed -$428K 625
2022
Q1
$428K Buy
+18,218
New +$423K 0.07% 306
2021
Q1
Sell
-7,401
Closed -$246K 751
2020
Q4
$246K Sell
7,401
-3,459
-32% -$126K 0.03% 609
2020
Q3
$349K Buy
+10,860
New +$312K 0.04% 494

Other funds holding INSM

Aigen Investment Management's INSM Position: Q4 2025 in Review

Aigen Investment Management sold out of Insmed (INSM) in Q4 2025, closing a stake of 4,465 shares — an estimated $643K sold.

Aigen Investment Management first reported a position in INSM in Q3 2020 and held it in 8 quarters. The position peaked at $1.61M in Q2 2025. 676 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Aigen Investment Management reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 4,465 Insmed shares in Q4 2025, an estimated $643K.
  • Aigen Investment Management first reported a position in Insmed in Q3 2020 and held it in 8 quarters.
  • Aigen Investment Management's Insmed position peaked at $1.61M in Q2 2025.
  • 676 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.